Search

Your search keyword '"Legendre, G"' showing total 564 results
Start Over Author "Legendre, G"
564 results on '"Legendre, G"'

1. Management of women with abnormal uterine bleeding: Clinical practice guidelines of the French National College of Gynaecologists and Obstetricians (CNGOF)

Author

Brun, J.L., Plu-Bureau, G., Huchon, C., Ah-Kit, X., Barral, M., Chauvet, P., Cornelis, F., Cortet, M., Crochet, P., Delporte, V., Dubernard, G., Giraudet, G., Gosset, A., Graesslin, O., Hugon-Rodin, J., Lecointre, L., Legendre, G., Maitrot-Mantelet, L., Marcellin, L., Miquel, L., Le Mitouard, M., Proust, C., Roquette, A., Rousset, P., Sangnier, E., Sapoval, M., Thubert, T., Torre, A., Trémollières, F., Vernhet-Kovacsik, H., Vidal, F., and Marret, H.

Published
2023
Full Text
View/download PDF

4. Prise en charge des ménorragies : recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF)

Author

Brun, J.-L., Plu-Bureau, G., Huchon, C., Ah-Kit, X., Barral, M., Chauvet, P., Cornelis, F., Cortet, M., Crochet, P., Delporte, V., Dubernard, G., Giraudet, G., Gosset, A., Graesslin, O., Hugon-Rodin, J., Lecointre, L., Legendre, G., Maitrot-Mantelet, L., Marcellin, L., Miquel, L., Le Mitouard, M., Proust, C., Roquette, A., Rousset, P., Sangnier, E., Sapoval, M., Thubert, T., Torre, A., Trémollières, F., Vernhet-Kovacsik, H., Vidal, F., and Marret, H.

Published
2022
Full Text
View/download PDF

8. Recommandations pour Pratique Clinique du Collège des Gynécologues Obstétriciens français 2021 : gestes prophylactiques associés en chirurgie gynécologique

Author

Touboul, C., Legendre, G., Agostini, A., Akladios, C., Bendifallah, S., Bolze, P.A., Bouet, P.E., Chauvet, P., Collinet, P., Dabi, Y., Delotte, J., Deffieux, X., Dion, L., Gauthier, T., Kerbage, Y., Koskas, M., Millet, P., Narducci, F., Ouldamer, L., Ploteau, S., Santulli, P., and Golfier, F.

Published
2021
Full Text
View/download PDF

15. Evaluating the safety of high-intensity focused ultrasound treatment for rectal endometriosis: results from a French prospective multicentre study including 60 patients.

Author

Dubernard, G, Maissiat, E, Legendre, G, Dennis, T, Capmas, P, Warembourg, S, Descamps, P, Chavrier, F, Roman, H, Fernandez, H, Nguyen-Ba, E, Merlot, B, Rousset, P, Lafon, C, and Philip, Charles-André

Subjects
HIGH-intensity focused ultrasound, ULTRASONIC therapy, THERAPEUTICS, VISUAL analog scale, ULTRASONIC waves
Abstract

STUDY QUESTION Is increasing the intensity of high-intensity focused ultrasound (HIFU) by 30% in the treatment of rectal endometriosis a safe procedure? SUMMARY ANSWER This study demonstrates the safety of a 30% increase in the intensity of HIFU in the treatment of rectal endometriosis, with no Clavien–Dindo Grade III complications overall, and namely no rectovaginal fistulae. WHAT IS KNOWN ALREADY A feasibility study including 20 patients with rectal endometriosis demonstrated, with no severe complications, a significant improvement in digestive disorders, dysmenorrhoea, dyspareunia, and health status, although the volume of the endometriosis nodule did not appear to be reduced. STUDY DESIGN, SIZE, DURATION A prospective multicentre cohort study was conducted between 2020 and 2022 with 60 patients with symptomatic rectal endometriosis. Following the failure of medical treatment, HIFU treatment was offered as an alternative to surgery. PARTICIPANTS/MATERIALS, SETTING, METHODS As the main objective of this study was to examine safety, all adverse events observed during the 6 months of follow-up were analysed and graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) and Clavien–Dindo classifications. Secondary objectives included evaluating the evolution of symptoms using validated questionnaires: gynaecological and digestive pain symptoms with a visual analogue scale, health status with the Medical Outcomes Study 36-item Short Form (SF-36) questionnaire, average post-operative daily pain level, and analgesic medication required in the 10 days following treatment. MRI was also performed at Day 1 to detect early complications. Finally, we performed a blinded MRI review of the evolution of the nodule at 6 months post-treatment. MAIN RESULTS AND THE ROLE OF CHANCE The procedure was performed under spinal anaesthesia for 30% of the patients. The median duration of treatment was 32 min. Fifty-five patients left the hospital on Day 1. MRI scans performed on Day 1 did not highlight any early-onset post-operative complication. Using the Clavien–Dindo classification, we listed 56.7% Grade I events, 3.4% Grade II events, and no events Grade III or higher. At 1, 3, and 6 months, all gynaecologic, digestive and general symptoms, as well as health status, had significantly improved. The evolution of the nodule was also significant (P  < 0.001) with a 28% decrease in volume. LIMITATIONS, REASONS FOR CAUTION The main objective was safety and not effectiveness. The study was not randomized and there was no control group. WIDER IMPLICATIONS OF THE FINDINGS HIFU treatment for rectal endometriosis results in an improvement of symptoms with low morbidity; as such, for selected patients, it could be a valuable alternative to surgical approaches following the failure of medical treatment. STUDY FUNDING/COMPETING INTEREST(S) The study was funded by the company EDAP TMS. Professors Dubernard and Rousset are consultants for EDAP TMS. Dubernard received travel support from EDAP-TMS. Dr F. Chavrier received industrial grants from EDAP-TMS. He has developed a device for generating focused ultrasonic waves with reduced treatment time. This device has been patented by EDAP-TMS. Dr Lafon received industrial grants from EDAP-TMS; he declares that EDAP-TMS provided funding directly to INSERM to support a young researcher chair in therapeutic ultrasound, which is unrelated to the current study. TRIAL REGISTRATION NUMBER ClinicalTrials.gov identifier NCT04494568. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. Tranexamic Acid for the Prevention of Blood Loss After Cesarean Delivery

Author

Sentilhes, L., Sénat, M.V., Le Lous, M., Winer, N., Rozenberg, P., Kayem, G., Verspyck, E., Fuchs, F., Azria, E., Gallot, D., Korb, D., Desbrière, R., Le Ray, C., Chauleur, C., de Marcillac, F., Perrotin, F., Parant, O., Salomon, L.J., Gauchotte, E., Bretelle, F., Sananès, N., Bohec, C., Mottet, N., Legendre, G., Letouzey, V., Haddad, B., Vardon, D., Madar, H., Mattuizzi, A., Daniel, V., Regueme, S., Roussillon, C., Benard, A., Georget, A., Darsonval, A., and Deneux-Tharaux, C.

Published
2021
Full Text
View/download PDF

25. Management of endometriosis: CNGOF/HAS clinical practice guidelines – Short version

Author

Collinet, P., Fritel, X., Revel-Delhom, C., Ballester, M., Bolze, P.A., Borghese, B., Bornsztein, N., Boujenah, J., Brillac, T., Chabbert-Buffet, N., Chauffour, C., Clary, N., Cohen, J., Decanter, C., Denouël, A., Dubernard, G., Fauconnier, A., Fernandez, H., Gauthier, T., Golfier, F., Huchon, C., Legendre, G., Loriau, J., Mathieu-d’Argent, E., Merlot, B., Niro, J., Panel, P., Paparel, P., Philip, C.A., Ploteau, S., Poncelet, C., Rabischong, B., Roman, H., Rubod, C., Santulli, P., Sauvan, M., Thomassin-Naggara, I., Torre, A., Wattier, J.M., Yazbeck, C., Bourdel, N., and Canis, M.

Published
2018
Full Text
View/download PDF

28. Recurrent pregnancy loss: current perspectives

Author

El Hachem H, Crepaux V, May-Panloup P, Descamps P, Legendre G, and Bouet PE

Subjects
Recurrent pregnancy loss, recurrent miscarriage, antiphospholipid syndrome, preimplantation genetic screening, preimplantation genetic diagnosis., Gynecology and obstetrics, RG1-991
Abstract

Hady El Hachem,1,2 Vincent Crepaux,3 Pascale May-Panloup,4 Philippe Descamps,3 Guillaume Legendre,3 Pierre-Emmanuel Bouet3 1Department of Reproductive Medicine, Ovo Clinic, Montréal, QC, Canada; 2Department of Obstetrics and Gynecology, University of Montreal, Montréal, QC, Canada; 3Department of Obstetrics and Gynecology, Angers University Hopsital, Angers, France; 4Department of Reproductive Biology, Angers University Hospital, Angers, France Abstract: Recurrent pregnancy loss is an important reproductive health issue, affecting 2%–5% of couples. Common established causes include uterine anomalies, antiphospholipid syndrome, hormonal and metabolic disorders, and cytogenetic abnormalities. Other etiologies have been proposed but are still considered controversial, such as chronic endometritis, inherited thrombophilias, luteal phase deficiency, and high sperm DNA fragmentation levels. Over the years, evidence-based treatments such as surgical correction of uterine anomalies or aspirin and heparin for antiphospholipid syndrome have improved the outcomes for couples with recurrent pregnancy loss. However, almost half of the cases remain unexplained and are empirically treated using progesterone supplementation, anticoagulation, and/or immunomodulatory treatments. Regardless of the cause, the long-term prognosis of couples with recurrent pregnancy loss is good, and most eventually achieve a healthy live birth. However, multiple pregnancy losses can have a significant psychological toll on affected couples, and many efforts are being made to improve treatments and decrease the time needed to achieve a successful pregnancy. This article reviews the established and controversial etiologies, and the recommended therapeutic strategies, with a special focus on unexplained recurrent pregnancy losses and the empiric treatments used nowadays. It also discusses the current role of preimplantation genetic testing in the management of recurrent pregnancy loss. Keywords: recurrent pregnancy loss, recurrent miscarriage, antiphospholipid syndrome, preimplantation genetic screening, preimplantation genetic diagnosis

Published
2017

49. Mioma y embarazo

Author

Debras, E., primary, Bouchghoul, H., additional, Vigoureux, S., additional, Neveu, M.-E., additional, Legendre, G., additional, Bendifallah, S., additional, Capmas, P., additional, and Fernandez, H., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results